During the prospective follow-up, 66 participants met McDonald 2010 diagnostic criteria for MS, while 11 were diagnosed as having a relapsing non-MS disease, 1 as having AQP4-positive neuromyelitis optica spectrum disorder, and 196 as having a monophasic course. The gene discussed is AQP4; the disease is myeloid sarcoma.